Hasil Pencarian - Xu-Feng Jiang

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial

    Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial oleh Qing Shi, Yang He, Hong‐Mei Yi, Rong‐Ji Mu, Xu‐Feng Jiang, Di Fu, Lei Dong, Wei Qin, Peng‐Peng Xu, Shu Cheng, Qi Song, Sai‐Juan Chen, Li Wang, Wei‐Li Zhao

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide

    JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide oleh Peng-Peng Xu, Yi-Feng Sun, Ying Fang, Qi Song, Zi-Xun Yan, Yi Chen, Xu-Feng Jiang, Xiao-Chun Fei, Yan Zhao, Christophe Leboeuf, Biao Li, Chao-Fu Wang, Anne Janin, Li Wang, Wei-Li Zhao

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden

    18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in pa... oleh Ling-Shuang Sheng, Rong Shen, Zi-Xun Yan, Chao Wang, Xin Zheng, Yi-Lun Zhang, Hao-Xu Yang, Wen Wu, Peng-Peng Xu, Shu Cheng, Emmanuel Bachy, Pierre Sesques, Nicolas Jacquet-Francillon, Xu-Feng Jiang, Wei-Li Zhao, Li Wang

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study

    Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker study oleh Mu‐Chen Zhang, Ying Fang, Peng‐Peng Xu, Lei Dong, Rong Shen, Yao‐Hui Huang, Di Fu, Zi‐Xun Yan, Shu Cheng, Xu‐Feng Jiang, Qi Song, Yang He, Yan Zhao, Min Lu, Jing Ye, Feng Liu, Lin Cheng, Chao‐Fu Wang, Li Wang, Wei‐Li Zhao

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: